NASDAQ
Opus Genetics, Inc. (IRD) reported revenue of $14.20M and net income of $-49,591,000 for FY 2025, with a net profit margin of -349.3%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.